Alon Harris, MS, PhD, FARVO
img_Alon Harris
PROFESSOR | Ophthalmology
PROFESSOR | Artificial Intelligence and Human Health
Research Programs
Dr. Harris’ research involves numerous national and international collaborations involving clinical trials, population based studies, and the development of new non-invasive imaging modalities for assessment of intracranial pressure, blood flow, and ocular structure and physiology. His identification of vascular risk factors related to minority disease disparity highlight his pursuit of improved diagnostic and disease management in vulnerable populations. Dr. Harris has also served as Director for several medical school courses, including both clinical research and minority focused risk factor assessment courses. He also served on the task force for establishing policies related to intellectual property.
Active Funding
Professor Harris currently serves as principal investigator for both NIH and NSF funded grants: R01EY030851 Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics NSF-DMS 1853222/1853303 Collaborative Research: Multiscale Modeling of Intraocular Pressure Dynamics and Its Role in Ocular Physiology and Pharmacology NYEE: Does COVID-19 Increase the Risk of Glaucoma Progression?
Founder and Editor: Journal for Modeling in Ophthalmology.
Professor Harris serves on numerous journal editorial boards and is the founder and editor of the Journal for Modeling in Ophthalmology. ___________________________________________________________________________________________________ Focus and Scope: While the rapid advance of imaging technologies in ophthalmology is making available a continually increasing number of data, the interpretation of such data is still very challenging and this hinders the advance in the understanding of ocular diseases and their treatment. Interdisciplinary approaches encompassing ophthalmology, physiology, mathematics and engineering have shown great capabilities in data analysis and interpretation for advancing basic and applied clinical sciences. The Journal for Modeling in Ophthalmology (JMO) was created in 2014 with the aim of providing a forum for interdisciplinary approaches integrating mathematical and computational modeling techniques to address open problems in ophthalmology. JMO welcomes articles that use modeling techniques to investigate questions related to the anatomy, physiology and function of the eye in health and disease. The objectives of JMO are: To provide a platform for the publication of modeling techniques applied to ophthalmology; To strengthen bridges across disciplines and disseminate information regarding open questions and novel interdisciplinary approaches to scientists with interests in ophthalmology, physiology, mathematics and engineering; To promote interdisciplinary collaborations that can deepen the understanding of ocular diseases and improve the care of patients. Authors are encouraged to address the multi-disciplinary JMO audience by explaining the details of the modeling approach as well as the scientific and clinical relevance of the results. JMO publishes full research articles, abstracts and editorials. Topics of interest to the journal include, but are not limited to: Biomechanics of ocular structures and fluids; Biophysics of ocular metabolism; Models for epidemiology and risk analysis; New techniques for data analysis and visualization; New techniques for disease prediction, including the use of genomic data; New animal models of complex eye disease. ___________________________________________________________________________________________________ Journal History: The Journal for Modeling in Ophthalmology (JMO) was created in November 2014 by Giovanna Guidoboni, Alon Harris and Simon Bakker with the aim of providing a forum for interdisciplinary approaches integrating mathematical and computational modeling techniques to address open problems in ophthalmology. The Editorial Board members include experts in ophthalmology, physiology, mathematics and engineering and strive to ensure the highest scientific level of the contributions selected for publication. The Journal for Modeling in Ophthalmology aims to be the voice for this rapidly growing interdisciplinary research and we hope you will join us on this exciting journey.

Undergrad, Wingate Institute

MS, Indiana University

PhD, Indiana University

Post Doctorate, Indiana University

Sam Rothberg Glaucoma Award

William and Mary Greve International Research Scholar Award

Research to Prevent Blindness

Glenn W. Irwin Jr., MD., Experience Excellence Recognition Award

Edmund Benjamin Spaeth Oration Award for Outstanding Clinical Research

American Academy of Ophthalmology Achievement Award

Letzter Endowed Chair of Ophthalmology

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Harris during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

  • Phileas Pharma
  • SlitLed
  • Adom

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Adom
  • Cipla
  • Qlaris

Editorial Services

  • none - editorial services

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • oxymap
  • Phileas Pharma
  • Qulent
  • SlitLed
  • Adom
  • Qlaris


  • Adom

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.